SARS-CoV-2 Omicron Variant is as Deadly as Previous Waves After Adjusting for Vaccinations, Demographics, and Comorbidities

The B.1.1.529 (Omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has previously been reported as more transmissible, but less severe than other SARS-CoV-2 variants. To test this assumption, we linked state-level vaccination data with quality-controlled electronic health records from a large healthcare system, including 13 hospitals, in Massachusetts, USA. We then performed a weighted case-control study to compare risks of hospital admission and mortality across the SARS-CoV-2 waves in over 130,000 COVID patients. Although the unadjusted rates of hospital admission and mortality appeared to be higher in previous waves compared to the Omicron period, after adjusting for confounders including various demographics, Charlson comorbidity index scores, and vaccination status (and holding the healthcare utilization constant), we found that the risks of hospitalization and mortality were nearly identical between periods. Our analysis suggests that the intrinsic severity of the Omicron variant may be as severe as previous variants.

[1]  Gheyath K Nasrallah,et al.  Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar , 2022, The New England journal of medicine.

[2]  N. Daneman,et al.  Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada. , 2022, JAMA.

[3]  A. Boon,et al.  Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques , 2022, bioRxiv.

[4]  W. Hanage,et al.  Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant. , 2022, The New England journal of medicine.

[5]  L. Bekker,et al.  Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa , 2021, The New England journal of medicine.

[6]  J. Bhiman,et al.  Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa , 2021, medRxiv.

[7]  D. Easton,et al.  Covid-19 Vaccine Effectiveness in New York State , 2021, The New England journal of medicine.

[8]  F. Dekker,et al.  An introduction to inverse probability of treatment weighting in observational research , 2021, Clinical Kidney Journal.

[9]  S. Murphy,et al.  Predicting COVID-19 mortality with electronic medical records , 2021, npj Digital Medicine.

[10]  N. Banholzer,et al.  Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave , 2021, medRxiv.

[11]  P. Venkatesan The changing demographics of COVID-19 , 2020, The Lancet Respiratory Medicine.

[12]  A. Raharja,et al.  ASSOCIATION BETWEEN ETHNICITY AND SEVERE COVID-19 DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. , 2020, medRxiv.

[13]  J. Manson,et al.  Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us , 2020, Annals of Internal Medicine.

[14]  Zhongheng Zhang,et al.  Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial. , 2017, Annals of translational medicine.

[15]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[16]  Kari Lock Morgan,et al.  Balancing Covariates via Propensity Score Weighting , 2014, 1609.07494.

[17]  P. Austin An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[18]  E C Alexopoulos,et al.  Introduction to multivariate regression analysis. , 2010, Hippokratia.

[19]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[20]  W. Hinsley,et al.  Report 50: Hospitalisation risk for Omicron cases in England , 2021 .